Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C
about
Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014.Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral loadNon-invasive diagnosis of hepatitis B virus-related cirrhosisComparison of accuracy of fibrosis degree classifications by liver biopsy and non-invasive tests in chronic hepatitis CNon-invasive assessment of liver fibrosis in chronic hepatitis C.A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients?Cost effectiveness of fibrosis assessment prior to treatment for chronic hepatitis C patients.Multiplex protein analysis to determine fibrosis stage and progression in patients with chronic hepatitis C.Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.Prediction of fibrosis in hepatitis C patients: assessment using hydroxyproline and oxidative stress biomarkers.Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease.Biomarkers of liver fibrosis.Prediction of esophageal variceal bleeding in B-viral liver cirrhosis using the P2/MS noninvasive index based on complete blood counts.The ability of Hepascore to predict liver fibrosis in chronic liver disease: a meta-analysis.Longitudinal assessment of hepatitis C fibrosis progression by collagen and smooth muscle actin morphometry in comparison to serum markers.Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection.Checkmate to liver biopsy in chronic hepatitis C?The prognostic values of 12 cirrhosis-relative noninvasive models in patients with hepatocellular carcinoma.Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver-prognosis in chronic hepatitis C.Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis CNon-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study.Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey.Prospective validation of P2/MS noninvasive index using complete blood counts for detecting oesophageal varices in B-viral cirrhosis.Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive.Combination of fibrosis tests: sequential or synchronous?A single blood test adjusted for different liver fibrosis targets improves fibrosis staging and especially cirrhosis diagnosis.Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
P2860
Q28082065-D68710EF-8758-4087-B80C-FD9303F8988EQ28479262-C83708F8-3C05-43AE-BF96-9975D2D38EA4Q30442641-E4DB8638-ADCA-4707-AF64-2DD139921310Q30471886-78E8C302-6F64-4A50-8598-DD218B4BA991Q30474738-CB6879DF-2C61-4A68-87AF-1854BDD97C3BQ30476922-F64519D4-9C6C-4506-B37D-73997F574FF5Q33665359-ACC82BA0-FC18-46F1-80C5-77F881D09FAAQ34098870-4A7D9446-7952-4A6B-8513-DB43846D62A2Q34476310-9330A48B-2FE0-4129-8F50-27378ABA75D9Q35594262-1B3CB674-3D2C-46AD-8672-E7231590D17CQ37404895-A7E444B2-83FA-4125-A9F6-D37F298BA16CQ37468027-B37A0EF8-2044-498C-9EAA-05DB227CF248Q37613375-A641A697-AA3C-4D0F-845A-41C7BC979DC2Q37825547-F564F81F-79A1-4D65-95EB-1F1CB1A0E853Q39551266-8AC84150-089D-40EB-A0B5-E012B1D7FBB8Q40749899-10A1A12B-93BA-4E04-964B-AFBC37A56E13Q40913201-6DCDF2BA-55FF-4137-8769-506B8547A551Q41628518-B5292652-93F5-45F3-9576-5BD80AE28E11Q41678369-A8449127-0FF4-4878-B58A-94072583B3F2Q41736718-874BEB80-001C-4581-A3AF-F18889BC9AEFQ42215056-CE23FD99-F72F-4908-B43E-37BFD3C8CBDCQ42318960-DE9E1490-C927-499D-8532-3944CCC549D7Q42997193-AC9714DF-E503-4B16-84EA-C251288AE7FBQ43056949-82BB196D-6740-4BC3-8843-E82F9BDA16A4Q43056978-EEAB8BED-5DDA-4F89-B880-4A1BF91A6C58Q43269083-27BBF023-3197-4EA6-9855-28EEFC357A32Q51534020-2424A4DE-0D3C-4E25-9603-635445321E8EQ51815031-3C93332C-6CE5-4264-9EB4-1E3FA6C1569BQ52605834-9B553F02-6D28-4667-872A-288F554D2356Q53257181-5FD79854-FA7A-4086-815F-A047E3C47C1A
P2860
Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evaluating the accuracy and in ...... ibrosis in chronic hepatitis C
@en
Evaluating the accuracy and in ...... brosis in chronic hepatitis C.
@nl
type
label
Evaluating the accuracy and in ...... ibrosis in chronic hepatitis C
@en
Evaluating the accuracy and in ...... brosis in chronic hepatitis C.
@nl
prefLabel
Evaluating the accuracy and in ...... ibrosis in chronic hepatitis C
@en
Evaluating the accuracy and in ...... brosis in chronic hepatitis C.
@nl
P2093
P2860
P1433
P1476
Evaluating the accuracy and in ...... ibrosis in chronic hepatitis C
@en
P2093
Anne de Muret
Frédéric Oberti
Gilles Hunault
Juliette Foucher
Jérôme Boursier
Marc Bourlière
Nathalie Sturm
Paul Calès
Philippe Halfon
Victor de Ledinghen
P2860
P304
P356
10.1111/J.1478-3231.2008.01789.X
P577
2008-05-19T00:00:00Z